Hot Topics:
- Commission’s Proposal for the Criteria to Identify Endocrine Disruptors- Report from the Competent Authorities
- Screening Methodology for Identification of Potential Endocrine Disrupting Substances
- Risk Assessment of Endocrine Disruptors in the US
- Adverse Outcome Pathways (AOPs) Focusing on Endocrine Active Chemicals
Presenting Institutions and Companies:
European Commission, Joint Research CentreSwedish Chemicals Agency (KEMI)
American 91AV Council
Czech National Institute for Public Health
Chemicals & Biocides, Environment Agency Austria
U.S. Environmental Protection Agency
Bayer AG
Dow AgroSciences Ltd
Charité Universitätsmedizin Berlin
Uppsala University
Dr. Knoell Consult GmbH
Utrecht University
Wageningen University
LyondellBasell Industries N.V.
University of Plymouth
BASF SE
Workshop
Alternative and New Methods in Endocrine Toxicity TestingDr Majorie B.M. van Duursen, Institute for Risk Assessment Sciences (IRAS), Utrecht University